Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

P301 L, an FTDP-17 Mutant, Exhibits Enhanced Glycation in vitro.

Journal of Alzheimer's disease : JAD - 1 Jan 2020

Sonawane Shweta Kishor, Chinnathambi Subashchandrabose

Abstract excerpt

BACKGROUND: Frontotemporal dementia and parkinsonism-linked to chromosome-17 are a group of diseases with tau mutations leading to primary tauopathies which include progressive supranuclear palsy, corticobasal syndrome, and frontotemporal lobar degeneration. Alzheimer's disease is a non-primary tauopathy, which displays tau neuropathology of excess tangle formation and accumulation. FTDP-17 mutations are...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Frontotemporal Dementia
Share to Microtubules
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neurons

Share to Protein Processing, Post-Translational

Share to tau Proteins

Share to Tauopathies

Source

Identifiers

PMID: 32250308
DOI: 10.3233/JAD-191348

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

P301 L, an FTDP-17 Mutant, Exhibits Enhanced Glycation in vitro.PMID 32250308Read ↗

Glycation potentiates neurodegeneration in models of Huntington's disease.Semantic proximity Read ↗

Tau Abnormalities and the Potential Therapy in Alzheimer’s DiseaseSemantic proximity Read ↗

Implications of Glycosylation in Alzheimer’s DiseaseSemantic proximity Read ↗

Dessert or Poison? The Roles of Glycosylation in Alzheimer's, Parkinson's, Huntington's Disease, and Amyotrophic Lateral SclerosisSemantic proximity Read ↗

Current Technologies Unraveling the Significance of Post-Translational Modifications (PTMs) as Crucial Players in NeurodegenerationSemantic proximity Read ↗

Early Stage Glycosylation Biomarkers in Alzheimer’s DiseaseSemantic proximity Read ↗

Role of Post‐translational Modifications in Alzheimer's DiseaseSemantic proximity Read ↗

Methylglyoxal reduces mitochondrial potential and activates Bax and caspase-3 in neurons: Implications for Alzheimer's disease.Semantic proximity Read ↗

Glycated alpha-synuclein assemblies cause distinct Parkinson’s disease pathogenesis in miceSemantic proximity Read ↗

Tau Post-Translational Modifications: Potentiators of Selective Vulnerability in Sporadic Alzheimer’s DiseaseSemantic proximity Read ↗

Removal of Pattern-breaking Sequences in Microtubule Binding Repeats Produces Instantaneous Tau Aggregation and ToxicitySemantic proximity Read ↗

Two-dimensional electrophoresis of tau mutants reveals specific phosphorylation pattern likely linked to early tau conformational changes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.